Issue 1, 2010

Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducers

Abstract

A series of chiral ruthenium polypyridyl complexes have been synthesized and evaluated for their in vitro anticancer activities. Λ-[Ru(bpy)2(o-tFMPIP)]Cl2 · 3H2O was identified as a novel mitochondria-targeted complex, which was able to induce mitochondria-mediated apoptosis in melanoma A375 cells through regulation of Bcl-2 family members and activation of caspases.

Graphical abstract: Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducers

Associated articles

Supplementary files

Article information

Article type
Concise Article
Submitted
27 Apr 2010
Accepted
05 Jun 2010
First published
16 Jun 2010

Med. Chem. Commun., 2010,1, 73-75

Chiral ruthenium polypyridyl complexes as mitochondria-targeted apoptosis inducers

T. Chen, W. Mei, Y. Wong, J. Liu, Y. Liu, H. Xie and W. Zheng, Med. Chem. Commun., 2010, 1, 73 DOI: 10.1039/C0MD00060D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements